DUBLIN--(BUSINESS WIRE)--The "Peripheral Vascular Devices Market Report Suite | United States | 2020-2026 | MedSuite" report has been added to ResearchAndMarkets.com's offering. One of the greatest ...
DUBLIN--(BUSINESS WIRE)--The "Atherectomy Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis" report has been ...
September 21 st, 2020; AngioDynamics, Inc. announced the launch of the Auryon Atherectomy System, a newly-developed innovative technology for the treatment of Peripheral Artery Disease (PAD),including ...
ST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Read the full report: https://www.reportlinker.com/p05988630/?utm_source=PRN Summary "Brazil Atherectomy Devices Market Outlook to 2025" is a comprehensive databook ...
The United States Atherectomy Devices Market is expected to expand from US$ 316.05 Million in 2024 to US$ 627.59 Million by 2033. The growth signifies an impressive Compound Annual Growth Rate (CAGR) ...
Dublin, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The "Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036" report has been added to ...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery ...
Please provide your email address to receive an email when new articles are posted on . The FDA has cleared a 225 cm radial access catheter for PAD atherectomy. Radial access may reduce bleeding risk ...
Based on type, the Peripheral vascular devices Market is segmented into Angioplasty balloons, Angioplasty stents, Catheters, Endovascular aneurysm repair stent grafts, Inferior cava filters, Plaque ...
For patients with peripheral arterial disease, the mainstay of initial treatment is always risk factor modification, ambulation, and compliance with guideline-based medical therapies. However, for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results